Arizona Cancer Center Biospecimen Repository
ConditionCancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Arizona
About this trial
RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer
NA
NA
Disqualifiers
None
Trial population
The goal of this protocol is to provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer by collecting and preserving tissue from the primary organ site, from the metastases, from patient blood (serum and lymphocytes), from patient urine, and from related samples of other tissues/fluids removed by the surgeon left over after diagnostic testing. No additional tissue will be taken at the time of surgery other than that required for patient care, but additional blood and urine samples will be obtained at that time. This protocol is not limited to certain types of cancer.
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
biologic sample preservation procedure
Other interventionbiologic sample preservation procedure
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Provision of tissue samples and biospecimens for translational study
An electronic record of the specimens is kept in a secure, web-based database. Follow-up information will be obtained from the patient medical record or from the patient.
Time frame
July 2024Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Arizona
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov